The role of autophagy in pulmonary microvascular endothelial cells (PMVECs) is controversial in LPS-induced acute lung injury (ALI). Mixed lineage kinase domain–like pseudokinase (MLKL) has recently been reported to maintain cell survival by facilitating autophagic flux in response to starvation rather than its well-recognized role in necroptosis. Using a mouse PMVEC and LPS-induced ALI model, we showed that in PMVECs, MLKL was phosphorylated (p-MLKL) and autophagic flux was accelerated at the early stage of LPS stimulation (1–3 h), manifested by increases in concentrations of lipidated MAP1LC3B/LC3B (microtubule-associated protein 1 light chain 3 β; LC3-II), decreases in concentrations of SQSTM1/p62 (sequestosome 1), and fusion of the autophagosome and lysosome by pHluorin-mKate2-human LC3 assay, which were all reversed by either MLKL inhibitor or siRNA MLKL. In mice, the inhibition of MLKL increased vascular permeability and aggravated mouse ALI upon 3-hour LPS stimulation. The p-MLKL induced by short-term LPS formed multimers to facilitate the closure of the phagophore by HaloTag-LC3 autophagosome completion assay. The charged multivesicular body protein 2A (CHMP2A) is essential in the process of phagophore closure into the nascent autophagosome. In agreement with the p-MLKL change, CHMP2A concentrations markedly increased during 1–3-hour LPS stimulation. CHMP2A knockdown blocked autophagic flux upon LPS stimulation, whereas CHMP2A overexpression boosted autophagic flux and attenuated mouse ALI even in the presence of MLKL inhibitor. We propose that the activated MLKL induced by short-term LPS facilitates autophagic flux by accelerating the closure of the phagophore via CHMP2A, thus protecting PMVECs and alleviating LPS-induced ALI.
Dexmedetomidine (DEX), a highly selective α2-adrenergic receptor agonist, is widely used for sedation and anesthesia in patients undergoing hepatectomy. However, the effect of DEX on autophagic flux and liver regeneration remains unclear. This study aimed to determine the role of DEX in hepatocyte autophagic flux and liver regeneration after PHx. In mice, DEX was intraperitoneally injected 5 min before and 6 h after PHx. In vitro, DEX was co-incubated with culture medium for 24 h. Autophagic flux was detected by LC3-II and SQSTM1 expression levels in primary mouse hepatocytes and the proportion of red puncta in AML-12 cells transfected with FUGW-PK-hLC3 plasmid. Liver regeneration was assessed by cyclinD1 expression, Edu incorporation, H&E staining, ki67 immunostaining and liver/body ratios. Bafilomycin A1, si-GSK3β and Flag-tagged GSK3β, α2-ADR antagonist, GSK3β inhibitor, AKT inhibitor were used to identify the role of GSK3β in DEX-mediated autophagic flux and hepatocyte proliferation. Pre- and post-operative DEX treatment promoted liver regeneration after PHx, showing 12 h earlier than in DEX-untreated mice, accompanied by facilitated autophagic flux, which was completely abolished by bafilomycin A1 or α2-ADR antagonist. The suppression of GSK3β activity by SB216763 and si-GSK3β enhanced the effect of DEX on autophagic flux and liver regeneration, which was abolished by AKT inhibitor. Pre- and post-operative administration of DEX facilitates autophagic flux, leading to enhanced liver regeneration after partial hepatectomy through suppression of GSK3β activity in an α2-ADR-dependent manner.
Sepsis-induced immunothrombosis is a principal driver of organ failure. It arises when innate antimicrobial defenses escalate into systemic thromboinflammatory injury. Autophagy, a conserved lysosomal degradation pathway, dynamically calibrates the procoagulant potential of macrophages, neutrophils, platelets and endothelial cells. This study reviews how distinct autophagic processes, including macroautophagy, mitophagy, chaperone-mediated autophagy and LC3-associated phagocytosis and xenophagy, govern the procoagulant behavior of these cells during sepsis. We propose a conceptual biphasic framework that processes stages from early compensatory autophagy to late-phase autophagic flux collapse and relate this temporal evolution to the clinical spectrum of sepsis-induced coagulopathy. Finally, we evaluate autophagy-targeted therapeutic strategies, including classic regulators, cell-specific nanodelivery systems and emerging gene-/RNA-targeted approaches, while emphasizing that most evidence remains mechanistic or preclinical. By integrating cellular heterogeneity with temporal dynamics, this review provides a mechanistic rationale for cell-targeted approaches to sepsis-induced coagulopathy.
5 November 2026 in Journal of Medical Case Reports
Background: Malignant hyperthermia (MH) is a rare but potentially fatal hypermetabolic crisis triggered by volatile anesthetics. Mortality rises sharply when dantrolene is delayed. MH upon re-exposure to volatile anesthetics is documented. Yet it is uncommon to encounter MH after a prior uneventful identical anesthetic, with onset beyond 2 hours, negative RYR1 and CACNA1S testing, and no on-site dantrolene. Case presentation: A male patient underwent laparoscopic resection of a recurrent adrenal lesion. He had received the same sevoflurane-based anesthetic at the same hospital 4 months earlier without incident. In this laparoscopic resection of a recurrent adrenal lesion, hypermetabolic signs initiated at approximately 2.0 hours after induction. The clinical diagnosis of MH was made at 2.5 hours after induction. The peak crisis of MH reached at 3.25 hours after induction, manifested by abrupt hypercapnia (EtCO 2 95 mmHg), hyperthermia to 40.5 °C, hyperkalemia (6.5 mmol/L) and metabolic acidosis. Blood pressure fell to 75/40 mmHg and heart rate rose to 165 beats per minute. Masseter spasm was absent. The Clinical Grading Scale score was 63 (“almost certain”). Sevoflurane was stopped immediately. The breathing circuit and soda lime were replaced. Management included hyperventilation, active cooling, correction of acidosis and electrolytes, and norepinephrine infusion. Our institution did not maintain an on-site dantrolene supply. Definitive therapy was delayed for 2 hours while the drug was retrieved from an outside facility. Postoperative targeted sequencing of RYR1 and CACNA1S revealed no pathogenic variants. The patient ultimately recovered without residual complications after ICU admission. Conclusions: This case demonstrates that MH can occur despite a prior uneventful anesthetic, despite negative RYR1/CACNA1S screening, and a 2-hours delay onset of MH. It underscores the necessity of maintaining institutional dantrolene stocks and sustained intraoperative vigilance regardless of anesthetic duration or prior unremarkable exposures.